SGLT2i use linked to lower risk for neurodegenerative disease in T2DM
By
HealthDay News
Sep 18, 2024
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
Dementia diagnoses up in individuals with acute kidney injury
By
Haymarket Media
Sep 05, 2024
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
More news for Wednesday, Aug. 14
By
Kimberly Bonvissuto
Aug 14, 2024
Update to HUD financing program supports construction of affordable housing … Morning Pointe of Greeneville earns deficiency-free health licensure survey … Lack of purpose, personal growth may precede...
To know or not to know, that is the question
By
John O'Connor
Aug 15, 2024
We live in an era where finding answers quickly is highly valued. But is faster always better?
Dementia may occur less often, develop slower in Parkinson’s disease patients
Aug 07, 2024
The median time to dementia was 15 years in the Penn cohort; the estimated probability of dementia at year 10 was 9 to 15% in the PPMI cohort.
Risk of Parkinson’s disease heightened in people with anxiety
Jul 22, 2024
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
New law calls for creation of ‘first-ever’ national plan, council to conquer Parkinson’s disease
By
Lois A. Bowers
Jul 08, 2024
The Department of Health and Human Services will form a federal advisory council that will provide recommendations for making progress against Parkinson’s disease, as well as implement a national plan...
Cardiac 18F-dopamine PET can predict Lewy body diseases
Nov 15, 2023
All nine LBD+ participants had low 18F-dopamine-derived radioactivity before or at the time of diagnosis of central Lewy body disease.